Moment of truth-adding carboplatin to neoadjuvant/adjuvant chemotherapy in triple negative breast cancer improves overall survival: An individual participant data and trial-level Meta-analysis-Reference-Cited by-同舟云学术

Moment of truth-adding carboplatin to neoadjuvant/adjuvant chemotherapy in triple negative breast cancer improves overall survival: An individual participant data and trial-level Meta-analysis

Published:2022-08 Issue: Volume:64 Page:7-18
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Pathak Neha^ORCID,Sharma Aparna,Elavarasi Arunmozhimaran,Sankar Jeeva,Deo S.V.S.,Sharma Daya N.,Mathur Sandeep,Kumar Sudhir,Prasad Chandra P.,Kumar Akash,Batra Atul^ORCID

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference40 articles.

1. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease;Bianchini;Nat Rev Clin Oncol,2016

2. Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer;Anders;Clin Breast Cancer,2009

3. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials;Lancet,2012

4. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies;Bd;J Clin Invest,2011

5. The resurgence of platinum-based cancer chemotherapy;Kelland;Nat Rev Cancer,2007

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial;Breast Cancer Research and Treatment;2023-08-14

2. Chemotherapy-induced exosomal circBACH1 promotes breast cancer resistance and stemness via miR-217/G3BP2 signaling pathway;Breast Cancer Research;2023-07-17

3. New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer;Diagnostics;2023-06-02

4. Optimal adjuvant treatment strategies for TNBC patients with residual disease after neoadjuvant treatment;Expert Review of Anticancer Therapy;2023-05-31

5. Pathologic Response to Neoadjuvant Sequential Chemoradiation Therapy in Locally Advanced Breast Cancer: Preliminary, Translational Results from the French Neo-APBI-01 Trial;Cancers;2023-03-29